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OBJECTIVES Our goals were to identify clinical and angiographic risk factors associated with major
cardiovascular complications of percutaneous coronary intervention (PCI) (in-hospital death,
Q-wave myocardial infarction, urgent or emergent coronary artery bypass surgery and stroke)
and to construct a simple score for risk stratification.
BACKGROUND Both clinical and angiographic features influence risk of PCIs.
METHODS Percutaneous coronary interventions performed between January 1, 1996, and December 31,
1999, were analyzed. Logistic regression and bootstrap methods were used to create an integer
risk score for estimating the risk of procedural complications using baseline, angiographic and
procedural characteristics. The risk score was tested in a validation-set consisting of all
procedures performed in the year 2000.
RESULTS Among 5,463 procedures, 5 clinical and 3 angiographic variables were significantly correlated
with procedural complications: cardiogenic shock, left main coronary artery disease, severe
renal disease, urgent or emergent procedure, congestive heart failure class III or higher,
thrombus, multivessel disease and older age. In the validation-set, the model fitted the data
adequately; the average receiver operating characteristic curve area was 0.782 (standard
deviation, 0.018).
CONCLUSIONS Eight variables were combined into a convenient bedside risk scoring system that estimates
the risk of complications after PCIs. (J Am Coll Cardiol 2002;40:387–93) © 2002 by the
American College of Cardiology Foundation
As percutaneous coronary intervention (PCI) techniques
have improved, the number of clinical and angiographic
indications for PCI has increased rapidly. Now PCI is
frequently performed in high-risk subgroups, such as elderly
patients and patients with left main coronary artery disease,
diffuse disease or cardiogenic shock, in whom PCI was
previously considered relatively contraindicated (1–3). The
benefits of PCI among these subgroups may be partially
offset by increased complication rates due to the inherent
risk. Assessment of the potential for benefit and the poten-
tial for harm is important for having informed discussions
with patients and families as various treatment options are
considered. Recent studies have reported improvements in
angiographic and clinical success rates of PCI among
high-risk groups, largely due to the availability of stents and
intravenous platelet glycoprotein (GP) receptor inhibitors
(4,5). Although procedural failure and complications still
occur, their causes may have changed (6–9).
The goals of the present study were: 1) to identify clinical
and angiographic risk factors associated with major cardio-
vascular complications in a consecutive series of PCIs
performed over a recent four-year period; 2) to construct a
simple risk score (based on those risk factors) for identifying
subgroups within various risk strata; and 3) to validate
internally the risk score using a consecutive one-year sample
of PCI procedures.
METHODS
Study population. At the time of PCI, patient-specific
data are entered into a prospective registry approved by the
Mayo Foundation Institutional Review Board. The registry
includes clinical, procedural and angiographic data on all
patients undergoing PCI. All patients are contacted at 6
months, 12 months and yearly thereafter by a clinical
research nurse. Medical records of all patients requiring
hospitalization at Mayo Clinic, or elsewhere, are reviewed
to further characterize any clinical events during follow-up.
Separate approval for the current study was obtained from
the Institutional Review Board. Patients who denied re-
search authorization were excluded from the study in
accordance with Minnesota law.
For data analysis and risk score construction, we included
PCIs that were performed between January 1, 1996, and
December 31, 1999 (study-set). Internal validation used
PCIs performed during 2000 (validation-set). The period
from 1996 to 1999 was chosen because: 1) stent deployment
became routine rather than being used only as a bail-out
treatment; 2) a thienopyridine was routinely added to
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aspirin therapy after stent deployment; and 3) parenteral GP
IIb/IIIa receptor antagonists became available. Only first-
time procedures were included.
End point. The outcome of interest was major complica-
tions, defined as one or more of the following: 1) in-hospital
death; 2) Q-wave myocardial infarction (MI); 3) urgent or
emergent coronary artery bypass graft surgery (CABG)
during the index hospitalization; and 4) cerebrovascular
accident. Myocardial infarction was diagnosed in the pres-
ence of two of the following three criteria: 1) chest pain for
at least 20 min; 2) elevation of creatine kinase (or the MB
fraction) 2 times normal; and 3) new Q waves on
electrocardiography. Other procedural complications, such
as non–Q-wave MI and vascular access site problems, were
not included in the present analysis. Patients who under-
went elective bypass surgery during hospitalization (n 20)
for severe residual disease were not included.
Baseline clinical characteristics. Baseline clinical charac-
teristics included age, gender, body mass index, history of
hypertension, diabetes, hypercholesterolemia (serum choles-
terol 6.21 mmol/l [240 mg/dl]), peripheral vascular dis-
ease, prior MI, prior CABG, Canadian Cardiovascular
Society angina class, New York Heart Association (NYHA)
heart failure class, smoking status and severe renal disease
(patients with serum creatinine 265 mol/l [3 mg/dl] or
patients receiving dialysis).
Indications for PCI. Indications for PCI were classified as
stable angina or unstable angina (defined as rest pain or
post-MI angina), acute MI or cardiogenic shock (defined as
systolic blood pressure 95 mm Hg or 110 mm Hg with
inotropic or intra-aortic balloon pump support, unrespon-
sive to fluid challenge or vasopressor therapy). Indications
for PCI were subclassified as elective or emergent (patient
with acute coronary syndrome brought into the cardiac
catheterization laboratory because of ongoing chest pain or
hemodynamic compromise or both).
PCI angiographic and procedural variables. The PCI
angiographic and procedural variables included: location of
the lesion; presence of multivessel disease (stenosis diameter
70% of vessel diameter in two or more epicardial coronary
arteries or their major branches); multivessel angioplasty;
type of lesion defined by the operator before the interven-
tion (American College of Cardiology/American Heart
Association [ACC/AHA] type A, B1, B2, or C); graft or
native vessel angioplasty; left main coronary artery disease
(stenosis diameter70% of vessel diameter); intervention of
unprotected left main coronary artery; intracoronary throm-
bus or presence of calcium at the lesion; PCI on a moderate
(45° to 90°) or severe (90°) bend; left ventricular function
(0.40); and use of intracoronary stents and GP IIb/IIIa
inhibitors.
Statistical methods. Logistic regression was used to model
the incidence of procedural complications and estimate odds
ratios. All p values were two-tailed. Characteristics signifi-
cant in univariate analysis were combined into an initial
model, and the bootstrap method was used to remove
variables to avoid overfitting the data (10–12). Two hun-
dred bootstrap samples were selected. Backward selection at
the 0.05 significance level was used to eliminate extraneous
variables in each sample. Variables that were selected in at
least 140 of the samples (70%) were included in the final
multivariate model.
To develop a simple risk prediction score, the risk factors
identified through multivariate modeling were assigned an
integer coefficient. Integers were chosen to be approximately
proportional to the estimated continuous coefficients from
the logistic model. The score starts at 0, and each risk
factor’s corresponding coefficient is added. The final score is
typically between 0 and 25. The patient population was
classified into five risk categories: 1) very low, 0 to 5; 2) low,
6 to 8; 3) moderate, 9 to 11; 4) high, 12 to 14; and 5) very
high, 15. Patients were ordered by the predictive risk and
separated into eight groups of similar size. Observed and
expected numbers of events were calculated within each
group. Model adequacy of the scoring system was then
evaluated with the Hosmer-Lemeshow goodness-of-fit test
(13,14). Within the study-set, discriminatory ability of the
score was assessed with another 200 bootstrap samples. The
risk score was calculated for each patient, and the area under
Table 1. Characteristics of Patients Undergoing 5,463 PCI
Procedures, 1996 to 1999
Variable
Patients*
No. %†
Male 3,847 70.4
Rest or post-MI angina 2,355 43.1
Acute MI 784 14.6
Preprocedure shock 226 4.2
Elective procedure 3,208 41.2
Prior CABG 1,082 19.8
Prior MI 2,969 54.9
Prior angioplasty 1,108 20.3
Hypertension 3,239 60.6
Diabetes 1,195 22.0
CHF on presentation 445 8.1
PVD 609 11.3
Severe renal disease 185 3.4
Glycoprotein IIb/IIIa inhibitor use 2,281 41.8
Stent use 4,481 82.0
Thienopyridine use 4,935 90.3
*Mean age  SD, 65.8  12 years. †Percentages are of patients with data available.
CABG  coronary artery bypass graft; CHF  congestive heart failure; MI 
myocardial infarction; PCI  percutaneous coronary intervention; PVD  peripheral
vascular disease.
Abbreviations and Acronyms
ACC/AHA  American College of Cardiology/
American Heart Association
CABG  coronary artery bypass graft surgery
GP  glycoprotein
MI  myocardial infarction
NYHA  New York Heart Association
PCI  percutaneous coronary intervention
ROC  receiver operating characteristic
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the receiver operating characteristic (ROC) curve was de-
termined for each sample. To study the performance of the
prediction rule on patient subgroups, the data were stratified
according to various clinical, procedural, and angiographic
variables.
For the validation-set of procedures performed during
2000, the predicted probabilities of in-hospital death,
Q-wave MI, stroke or need for emergent CABG were
calculated from the integer risk score. Model discrimination
was assessed by ROC curve analysis, and goodness-of-fit
was tested with the Hosmer-Lemeshow statistic.
RESULTS
A total of 5,463 patients undergoing first PCI procedures were
included in the study-set performed between January 1, 1996,
and December 31, 1999. There were 112 deaths (2.1%), 54
Q-wave MIs (1.0%), 50 urgent or emergent CABG operations
(0.9%) and 28 strokes observed (0.5%) during the index
hospitalization. The composite end point (i.e., any major
complication) occurred in 220 procedures (4.0%).
Baseline clinical characteristics. Mean age ( SD) of the
patients was 65.8  12 years, 70.4% were men, 43.1%
presented with unstable angina and 14.6% presented with
acute MI (Table 1). At the time of the procedure, 4.2% of
the patients were in cardiogenic shock. The prevalence of
risk factors is shown in Table 1: 60.6% had hypertension,
22% had diabetes, 11.3% had peripheral vascular disease and
3.4% had severe renal disease.
Clinical correlates of procedural complications. Univari-
ate associations between baseline demographic characteris-
tics and adverse outcomes, with odds ratios and confidence
intervals, are shown in Table 2. The significant correlates
included preprocedural shock, NYHA class III, conges-
tive heart failure on presentation, severe renal disease,
treatment of acute MI, peripheral vascular disease and age
(by decade). The following variables were not significantly
associated with procedural complications: unstable angina,
diabetes, hypertension, hypercholesterolemia and current
smoking status. Elective procedures and male gender were
associated with reduced rates of complications.
Table 2. Association of Clinical Characteristics and Complications After PCI
Variable
Procedural
Complications
(%)*
Odds
Ratio
95%
Confidence
Interval p Value
Age (yrs)
50 1.3 1.00 NA
50 to 60 2.4 1.84 0.8–4.1 0.13
60 to 70 3.9 3.06 1.5–6.4 0.003
70 to 80 5.0 3.89 1.9–8.1  0.001
80 7.5 6.03 2.8–12.9  0.001
Gender 0.007
Male 3.6 1.00 NA
Female 5.1 1.47 1.1–1.9
Acute MI 9.4 3.27 2.4–4.4  0.001
Preprocedural shock 25.2 10.45 7.4–14.7  0.001
Urgent or emergent procedure 5.6 3.39 2.4–4.8  0.001
Prior CABG 5.1 1.37 1.0–1.9 0.05
Diabetes 4.9 1.30 1.0–1.8 0.09
PVD 7.4 2.15 1.5–3.0  0.001
Serum creatinine 265 mol/l† 11.4 3.29 2.0–5.3  0.001
*Percentages are of patients with data available. †3 mg/dl.
CABG  coronary artery bypass graft; MI  myocardial infarction; NA  not applicable; PCI  percutaneous coronary
intervention; PVD  peripheral vascular disease.
Table 3. Association of Angiographic and Procedural Characteristics and Complications After PCI
Variable
Patients
(%)*
Procedural
Complications
(%)
Odds
Ratio
95%
Confidence
Interval p Value
Left main coronary artery disease† 1.6 25.8 9.16 5.6–15.0  0.001
Left main coronary artery intervention 2.0 16.4 4.99 3.0–8.4  0.001
Thrombus 37.7 6.5 2.87 2.1–3.8  0.001
Multivessel disease 51.0 5.7 2.69 2.0–3.7  0.001
Type C lesion treated 46.0 4.9 2.35 1.7–3.3  0.001
Vein graft intervention 9.1 6.6 1.82 1.2–2.7 0.002
Calcified stenosis 43.3 4.8 1.61 1.2–2.1 0.001
Proximal LAD intervention 18.3 5.3 1.44 1.0–2.0 0.03
*Percentages are of patients with data available. †Stenosis diameter 70% of vessel diameter.
LAD  left anterior descending coronary artery; PCI  percutaneous coronary intervention.
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Angiographic characteristics and procedural com-
plications. High-risk characteristics such as presence of
thrombus (37.7%), multivessel (51%) or left main coronary
artery disease (1.6%) and type C treated lesions (46%) were
frequent (Table 3). Variables significantly associated with
procedural complications after PCI included left main
coronary artery disease or intervention, thrombus, calcifica-
tion, multivessel disease, and ACC/AHA type C lesion.
Vein graft and proximal left anterior descending coronary
artery lesions were also associated with procedural compli-
cations.
Multivariable correlates. Five clinical and three angio-
graphic variables were selected in at least 70% of the
multivariable analyses of the bootstrap samples. The vari-
ables (fitted to the original data) were the following:
presence of cardiogenic shock, left main coronary artery
disease, severe renal disease, an urgent or emergent proce-
dure, congestive heart failure class III, thrombus, mul-
tivessel disease and age (Table 4). The data did not deviate
significantly from the logistic model, as indicated by the
nonsignificant Hosmer-Lemeshow test result (p  0.93)
(Fig. 1). The mean area ( SD) under the ROC curve of
the bootstrap samples was 0.782 (0.018), indicating a
good ability to discriminate between patients who had
complications during the index hospitalization and those
who did not.
Subgroup analysis. The discriminatory ability of the pre-
diction equation as measured by the area under the ROC
curve (c) was calculated for each group (Table 5). In general,
model discriminatory power was better among high-risk
subgroups (patients with diabetes or left main coronary
artery interventions, for example) than among low-risk
subgroups (patients who had elective procedures).
Risk score. On the basis of the integer risk score, 2,145
procedures (39.3%) were classified as very low risk; 2,182
(39.9%), low risk; 809 (14.8%), moderate risk; 210 (3.8%),
high risk; and 117 (2.1%), very high risk. The observed rates
of procedural complications (and the expected range of risk)
in these strata were 1.0% (2%) for very low-risk; 3.0%
(2% to 5%), low-risk; 6.2% (5% to 10%), moderate-risk;
19.5% (10% to 25%), high-risk; and 35.0% (25%), very
high-risk (Fig. 2).
Validation-set. A total of 1,781 PCI procedures were
performed during 2000, with 58 adverse events among these
procedures. The model predicted 72.3 events (a difference of
1 event per 100 procedures). In the validation data set, the
Table 4. Multivariate Predictors of Procedural Complications After PCI
Variable
Integer
Score
Model
Coefficient*
Odds
Estimate
95%
Confidence
Interval p Value
Cardiogenic shock 5 1.599 4.95 3.4–7.2  0.001
Left main coronary artery disease 5 1.467 4.34 2.5–7.6  0.001
Serum creatinine 265 mol/l† 3 0.881 2.41 1.4–4.2 0.001
Urgent or emergent procedure 2 0.758 2.13 1.5–3.1  0.001
NYHA III 2 0.745 2.11 1.4–3.1  0.001
Thrombus 2 0.644 1.90 1.4–2.6  0.001
Multivessel disease 2 0.618 1.86 1.3–2.6  0.001
Age, no. of decades after 30 years 1 0.313 1.37 1.2–1.6  0.001
Intercept NA 5.965 NA NA NA
*Model 28 293.3, p  0.001; mean  SD for bootstrap receiver operating characteristic areas, 0.782  0.018. †3 mg/dl.
NA  not applicable; NYHA  New York Heart Association classification; PCI  percutaneous coronary intervention.
Figure 1. Expected versus observed procedural complications after percu-
taneous coronary intervention in clinical practice. Hosmer-Lemeshow
goodness-of-fit test (6 df)  1.83, p  0.93.
Table 5. Validation-Set Model Evaluation by Various Baseline,
Procedural, and Angiographic Characteristics
Subgroup
Procedural Failures ROC
Curve
AreaNo. n
Age (yrs)
65 57 2,380 0.79
65 163 3,083 0.76
Gender
Female 83 1,616 0.74
Male 137 3,847 0.80
Acuity
Urgent or emergent 181 3,208 0.77
Elective 39 2,248 0.69
CHF on presentation 50 445 0.80
Prior CABG 55 1,082 0.73
Diabetes 58 1,195 0.84
CABG  coronary artery bypass graft; CHF  congestive heart failure; ROC 
receiver operating characteristic.
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area under the ROC curve was 0.755, and the Hosmer-
Lemeshow statistic p value was 0.64 (26  4.25),
indicating that the model fitted the data well and typically
correctly ranked patient risk (Fig. 3). Generally, patients
who died had higher risk scores than those who did not (c
statistic, 0.88), although this did not hold as well for
patients who had a Q-wave MI, stroke or emergency
CABG (c statistic, 0.684, 0.719 and 0.641, respectively).
Among the 607 elective PCI procedures, there were 8
complications, whereas the model predicted 10 (c statis-
tic, 0.595). Thus, although the model was accurate for
elective patients as a group, individual patients who
experienced complications were only slightly more likely
to have higher risk scores than were patients who had no
complications.
DISCUSSION
The present study identifies clinical, angiographic and
procedural variables that are significantly associated with
procedural complications after PCI in current practice. This
model has been internally validated. Our study documents
the usefulness of readily available clinical and angiographic
variables in estimating procedural complication rates in the
current era of stents and GP IIb/IIIa receptor inhibitors.
We developed a risk score for procedural complications after
PCI in a simple integer-scoring scheme that can be readily
applied at the bedside.
Comparison with previous studies. Ellis et al. (8) pro-
posed an angiographic risk assessment scheme and found a
strong correlation between complications after PCI and
intervention in degenerated vein grafts and recent total
occlusions. Our goal was to develop a risk score incorporat-
ing clinical and angiographic evaluations that are commonly
available to clinicians before PCI. For risk prediction we
found that clinical variables were as important as angio-
graphic variables. In particular, age, the presence of shock or
severe congestive heart failure, severe renal disease and
procedural urgency were correlated with procedural compli-
cations, along with angiographic variables such as stenosis of
the left main coronary artery, thrombus and presence of
multivessel disease.
The Northern New England Cardiovascular Disease
Study Group performed a multivariate analysis of in-
hospital mortality (but not other major complications) in a
data set of 15,331 patients who had PCI performed between
1994 and 1996 (6). Since 1996, however, PCI practice has
changed considerably, with higher utilization rates of stents
and glycoprotein IIb/IIIa inhibitors. Nonetheless, factors
associated with in-hospital mortality were similar to our
findings; they included old age, lower ejection fraction,
cardiogenic shock, treatment of an acute MI, urgent and
emergent priority, type C lesions and use of a preprocedure
intra-aortic balloon pump.
In two prior studies from our laboratory, we documented
Figure 2. Estimated rates of procedural complications for the integer scoring system. The integers are proportional to the estimated continuous coefficient
from the logistic model. Percentages at risk are shown for each of the five risk categories: 2% is very low risk for complications with coronary angioplasty;
2% to 5%, low risk;5% to 10%, moderate risk;10% to 25%, high risk; and25%, very high risk. NYHANew York Heart Association classification.
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the potential of the New York State multivariate risk score
for predicting overall procedural mortality—but not other
clinically important complications (9,15). The current study
further demonstrates the utility of simple clinical prediction
rules for complications after PCI. Several other studies have
analyzed the risk factors associated with PCI, but they were
performed in an era antedating current practice (16–18).
Clinical application. When considering treatment op-
tions, the potential for benefit must be weighed against the
potential for harm for each option. For invasive procedures,
in general, long-term benefit can be partially offset by
procedural risk. Our risk score allows rapid bedside strati-
fication of patients into five risk strata. It should be
recognized that no model can predict which individual
patients will experience complications (the “crystal ball
approach”); however, the model can estimate the likelihood
of a major PCI complication. Insofar as probabilistic esti-
mates of risk and benefit are useful in clinical decision
making, clinicians may find the model contributory.
Models such as ours, if externally validated, may also be
useful as benchmarking mechanisms for hospitals and op-
erators. Over large numbers of procedures, expected rates of
complications can be calculated and compared with ob-
served rates.
Study limitations. Although no specific subsets of patients
were excluded, the current analysis is derived from the data
set of a single referral center, and broader applicability is
open to question. Operator volume was not considered in
the current analysis (19). Independent validation in other
data sets is needed. Perhaps the greatest limitation of any
model in prediction of PCI complications is that discrimi-
natory ability for individual elective patients is limited
because of the overall low probability of an event. Over 95%
of the elective interventions in the validation-set had pre-
dicted complication rates under 4%. As PCI procedures
become safer, discriminatory ability will inevitably erode.
Conclusions. Clinical and angiographic characteristics are
equally important in determining procedural risk with PCI.
We developed and internally validated a simple integer risk
score for prediction of major in-hospital complications after
PCI. Five clinical variables (age, cardiogenic shock, conges-
tive heart failure, renal failure and urgent or emergent PCI)
and three angiographic variables (thrombus, multivessel
disease and left main disease) can be used to accurately
risk-stratify subgroups of patients undergoing PCI. This
score was developed from a data set with low rates of
missing values and with high rates of stent use and paren-
teral antiplatelet-agent use. This model may help clinicians
assess procedural risk.
Reprint requests and correspondence: Dr. Charanjit S. Rihal,
Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905.
E-mail: rihal@mayo.edu.
Figure 3. The observed and corresponding predicted procedural complications in the validation-set with the proposed risk score. The x-axis represents the
risk score in the validation-set. The y-axis represents the complication rate. The solid line demonstrates the predicted procedural complications derived
from the risk score. The bars represent observed procedural complications in the validation-set. Three patients had a score  19; all three were free of
complications.
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